The single-arm, open-label DR-OVP-002 study is currently evaluating Ovaprene in sexually active women aged 18 to 40 years who are at risk for pregnancy or desiring contraception.

FirstLight and RadiantLight evaluated the safety and efficacy of oveporexton for the treatment of narcolepsy with cataplexy in participants aged 16 to 70 years old.

Baxdrostat is an investigational highly selective, oral, small molecule designed to inhibit aldosterone synthase.

The approval was supported by data from the randomized, double-blind, placebo-controlled, event-driven phase 3 FINEARTS-HF study.

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to TSND-201 (methylone) for the treatment of posttraumatic stress disorder (PTSD).

The Food and Drug Administration (FDA) has accepted the New Drug Application for doravirine/islatravir (DOR/ISL) for adults with virologically-suppressed HIV-1 infection.

Cannabidiol within the range consumers are taking with unregulated products linked to increase in liver enzymes ...

Even more concerning? The loss of data. The US funded most HIV tracking systems in Africa, and many have now stopped collecting patient and hospital records.

The USPSTF meets several times a year to review the latest science and decide which screenings, medications and other preventive services should be fully covered by insurance.

However, childhood cancer survivors have lower risk for registered COVID-19 infection relative to comparators.

Introduction of immune checkpoint inhibitors linked to widening disparity for those with private insurance versus those without insurance.

The Food and Drug Administration (FDA) has updated the labeling for Kisunla ™ (donanemab-azbt) to include a new recommended titration dosing schedule for adults with early symptomatic Alzheimer ...